Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 15,421–15,440 of 17,987 drug recalls

Drug Recall Terminated Historical recordClass II

Testosterone Cypionate 100mg/ml

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Terbutaline/Ipratropium 0.5mg/2.5ml

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Tacrolimus 0.02% opth. (H20-based)

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Tacrolimus (H20-based) 0.03% ophth.

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Tetracaine 0.5% ophth.

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Scopolamine 0.25 opth.

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Sodium Bicarbonate 8.4% inj.

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Renacidin Irrigation

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Pyridoxine (p-f) 100mg/ml

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Prostaglandin all combinations

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Papaverine 12mg/phent 1mg/Pros 9mcq/ml

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Papaverine 1nj 30mg/ml

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Novarel (IM)

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Methylcobalamin

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Methotrexate Intraocular 400mcg 0.1cc

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Idoxuridine 0.1% Ophthalmic

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Hydroxyprogesterone Caproate

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Hydroxocobalamin inj.

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Glutathione Inhalation 200mg/5ml

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Glutathione 1.25%/Ascorbic 1.25%/DMSO 6.25%

by Natures Pharmacy & Compounding Center

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
November 1, 2013
Reported by FDA
March 12, 2014
Distribution
NC

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.